ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0843

Predictive Validity of Data-driven Definitions for Active and Structural Lesions in the SI Joints Typical for Axial SpA: A 2-year Follow-up in the SPondyloArthritis Caught Early Cohort

Liese de Bruin1, Mary Lucy marques2, Miranda Van Lunteren3, Manouk de Hooge4, Sofia Exarchou5, Floris Van Gaalen3, Désirée van der Heijde6 and Sofia Ramiro6, 1Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center; Centro Hospitalar e Universitário de Coimbra (Department of Rheumatology), Coimbra, Portugal, 3Leiden University Medical Center, Department of Rheumatology, Leiden, Netherlands, 4Ghent University Hospital, Hesperange, Luxembourg, 5Lund University, Åkarp, Sweden, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: ACR Convergence 2023

Keywords: Diagnostic criteria, Magnetic resonance imaging (MRI), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes I: AxSpA

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: The Assessment of Spondyloarthritis international Society MRI (ASAS MRI) group has proposed definitions for active and structural lesions typical for axial SpA (axSpA) on SI joint MRI (MRI-SIJ), based on high specificity and positive predictive values (PPV; ≥95%) for the rheumatologist’s diagnosis of axSpA (Maksymowych et al., 2021). These cut-offs have not been validated in other cohorts nor assessed in early disease. Here, we analyze the predictive validity of the proposed cut-offs for active and structural MRI-SIJ lesions in early axSpA after 2 years follow-up.

Methods: Patients with chronic back pain (unknown origin; ≥3 months; ≤2 years; onset < 45 years) from the SpA Caught Early (SPACE) inception cohort were followed-up and diagnosed (axSpA/no axSpA) by a rheumatologist after 2 years (Marques et al., 2023). Three central readers scored baseline MRI-SIJ for bone marrow edema (BME), erosion, fat lesions, and sclerosis. Patients with a certain (level of confidence about the diagnosis ≥7) or very probable (level of confidence < 7 and a consistent diagnosis in the last 2 available visits) diagnosis were included for analysis. When data were available for ≥2 readers, the MRI SIJ were analyzed for consensus between ≥2 readers on scored lesions and each individual reader. The lesions were assessed for quadrants, consecutive slices, or combinations between different lesions (Table 1 & 2). We calculated sensitivity, specificity, PPV and negative predictive values (NPV) for each cut-off. Based on consensus, a combination of specificity ≥95% and PPV ≥95% was required for a cut-off to be considered validated. For the individual readers, a PPV of ≥94% in ≥2 readers was accepted.

Results: We analyzed 447 patients (age 30 (SD 8) years; 45% males; 66% axSpA). BME in ≥1 quadrant, or ≥2 consecutive slices met the threshold based on consensus (Table 1). BME in ≥2 quadrants or ≥2 consecutive slices met the threshold in ≥2 individual readers (Table 1 & 2). Erosions in ≥2 quadrants or ≥4 consecutive slices, and fat in ≥1 quadrant or ≥2 consecutive slices met the threshold based on consensus. Erosion in ≥3 consecutive slices met the threshold in ≥2 individual readers, and fat in ≥2 quadrants or ≥3 consecutive slices met the threshold in all individual readers. All combinations of BME-fat met the threshold based on consensus (Table 1). Combinations of BME-erosions and fat-erosion in ≥1 quadrants, each and/or one of both ≥2 quadrants, or ≥3 quadrants with fat lesions and/or ≥2 quadrants with erosion met the threshold based on consensus. Combined lesions did not outperform single item lesions.

Conclusion: In early axSpA, the proposed ASAS MRI cut-offs for active SIJ lesions have been validated in consensus and individual reading. For structural SIJ lesions, the proposed cut-offs for fat in quadrants and consecutive slices as well for erosions in quadrants have been confirmed. However, we propose a higher cut-off of ≥4 consecutive slices for erosions. All these cut-offs have now shown a high specificity and PPV in both early and established axSpA.

Supporting image 1

Supporting image 2


Disclosures: L. de Bruin: None; M. marques: None; M. Van Lunteren: None; M. de Hooge: UCB, 6; S. Exarchou: Amgen, 2, Janssen, 2, Novartis, 2, UCB Pharma, 2; F. Van Gaalen: AbbVie, 12, Personal fees, BMS, 12, Personal fees, Eli Lilly, 12, Personal fees, Jacobus Stichting, 5, MSD, 12, Personal fees, Novartis, 5, 12, Fees, Stichting ASAS, 5, Stichting Vrienden van Sole Mio, 5, UCB Pharma, 5; D. van der Heijde: AbbVie, 2, Bayer, 2, BMS, 2, Eli Lilly, 2, Galapagos, 2, Gilead, 2, GSK, 2, Imaging Rheumatology BV, 12, Director, Janssen, 2, Novartis, 2, Pfizer, 2, Takeda, 2, UCB Pharma, 2; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, Galapagos, 5, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, UCB Pharma, 2, 5.

To cite this abstract in AMA style:

de Bruin L, marques M, Van Lunteren M, de Hooge M, Exarchou S, Van Gaalen F, van der Heijde D, Ramiro S. Predictive Validity of Data-driven Definitions for Active and Structural Lesions in the SI Joints Typical for Axial SpA: A 2-year Follow-up in the SPondyloArthritis Caught Early Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/predictive-validity-of-data-driven-definitions-for-active-and-structural-lesions-in-the-si-joints-typical-for-axial-spa-a-2-year-follow-up-in-the-spondyloarthritis-caught-early-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-validity-of-data-driven-definitions-for-active-and-structural-lesions-in-the-si-joints-typical-for-axial-spa-a-2-year-follow-up-in-the-spondyloarthritis-caught-early-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology